Literature DB >> 23814291

Deprescribing: what is it and what does the evidence tell us?

Wade Thompson1, Barbara Farrell.   

Abstract

Year:  2013        PMID： 23814291      PMCID： PMC3694945          DOI： 10.4212/cjhp.v66i3.1261

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  7 in total

Review 1.  Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes.

Authors:  Danijela Gnjidic; David G Le Couteur; Lisa Kouladjian; Sarah N Hilmer
Journal:  Clin Geriatr Med       Date:  2012-02-21       Impact factor: 3.076

2.  Polypharmacy and falls in the middle age and elderly population.

Authors:  G Ziere; J P Dieleman; A Hofman; H A P Pols; T J M van der Cammen; B H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

3.  Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial.

Authors:  A J Campbell; M C Robertson; M M Gardner; R N Norton; D M Buchner
Journal:  J Am Geriatr Soc       Date:  1999-07       Impact factor: 5.562

4.  Polypharmacy status as an indicator of mortality in an elderly population.

Authors:  Johanna Jyrkkä; Hannes Enlund; Maarit J Korhonen; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 5.  Polypharmacy in elderly patients.

Authors:  Emily R Hajjar; Angela C Cafiero; Joseph T Hanlon
Journal:  Am J Geriatr Pharmacother       Date:  2007-12

6.  The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people.

Authors:  Doron Garfinkel; Sarah Zur-Gil; Joshua Ben-Israel
Journal:  Isr Med Assoc J       Date:  2007-06       Impact factor: 0.892

Review 7.  Medication withdrawal trials in people aged 65 years and older: a systematic review.

Authors:  Shoba Iyer; Vasi Naganathan; Andrew J McLachlan; David G Le Couteur
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923
  7 in total
  37 in total

1. 

Authors:  Peter J Zed
Journal:  Can J Hosp Pharm       Date:  2018-10-31

2.  Deprescribing Proton Pump Inhibitors.

Authors:  Peter J Zed
Journal:  Can J Hosp Pharm       Date:  2018-10-31

3.  Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

Authors:  Barbara Farrell; Kevin Pottie; Wade Thompson; Taline Boghossian; Lisa Pizzola; Farah Joy Rashid; Carlos Rojas-Fernandez; Kate Walsh; Vivian Welch; Paul Moayyedi
Journal:  Can Fam Physician       Date:  2017-05       Impact factor: 3.275

Review 4.  A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.

Authors:  Emily Reeve; Danijela Gnjidic; Janet Long; Sarah Hilmer
Journal:  Br J Clin Pharmacol       Date:  2015-12       Impact factor: 4.335

5.  Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid.

Authors:  Wade Thompson; Barbara Farrell; Vivian Welch; Peter Tugwell; Lise M Bjerre
Journal:  Can Pharm J (Ott)       Date:  2016-11-30

6.  Psychoactive medication use among older community-dwelling Americans.

Authors:  Yara K Haddad; Feijun Luo; Mamta V Karani; Zachary A Marcum; Robin Lee
Journal:  J Am Pharm Assoc (2003)       Date:  2019-06-14

Review 7.  Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis.

Authors:  Hanna E Bloomfield; Nancy Greer; Amy M Linsky; Jennifer Bolduc; Todd Naidl; Orly Vardeny; Roderick MacDonald; Lauren McKenzie; Timothy J Wilt
Journal:  J Gen Intern Med       Date:  2020-08-20       Impact factor: 5.128

Review 8. 

Authors:  Lise M Bjerre; Barbara Farrell; Matthew Hogel; Lyla Graham; Geneviève Lemay; Lisa McCarthy; Lalitha Raman-Wilms; Carlos Rojas-Fernandez; Samir Sinha; Wade Thompson; Vivian Welch; Andrew Wiens
Journal:  Can Fam Physician       Date:  2018-01       Impact factor: 3.275

Review 9.  Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.

Authors:  Lise M Bjerre; Barbara Farrell; Matthew Hogel; Lyla Graham; Geneviève Lemay; Lisa McCarthy; Lalitha Raman-Wilms; Carlos Rojas-Fernandez; Samir Sinha; Wade Thompson; Vivian Welch; Andrew Wiens
Journal:  Can Fam Physician       Date:  2018-01       Impact factor: 3.275

10.  Deprescribing practices for anticonvulsants after benign seizures secondary to high-dose tranexamic acid in a single, large UK cardiothoracic centre.

Authors:  Zihui Tan; Choo Yen Ng; David Jenkins; Linda Barrow; Kamen Valchanov
Journal:  Eur J Hosp Pharm       Date:  2019-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.